Contact Us | Find An Expert

Find an Expert
a

World Glaucoma Week

Celebrate World Glaucoma Week: March 6th – 12th, 2022

World Glaucoma Week is celebrated every March– Join Living with Glaucoma and other members of the glaucoma community to spread the word and raise awareness!

What is World Glaucoma Week?

World Glaucoma Week is a global initiative of the World Glaucoma Association (WGA) in order to raise awareness on glaucoma.

A whopping 400+ activities were posted on the official World Glaucoma Week 2021 World Map, reaching all corners of the world. Thank you for being a part of our global community!

Learn More

Save the Date for Next Year: March 6-12, 2022

How You Can Get Involved

When it comes to glaucoma, lack of awareness may cause severe issues, that could even lead to permanent vision loss. And as glaucoma isn’t always under the radar, the World Glaucoma Week activities are crucial.

Participating in World Glaucoma Week is easy:

Get Inspired

In need of inspiration for the next World Glaucoma Week? Start by browsing past celebrations!

View Archives

Download Assets

Download the World Glaucoma Week toolkit with logo, banners & more to create your own artwork.

Get Toolkit

Get Screened

Sign up to be notified about free screening locations near you.

Complete Form

Hear from Glaucoma Patients Just Like You

Read patient stories, blogs, and more!

view options

Importance of Getting Screened for Glaucoma

News coverage body content sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donc aenean lacinia bibendum nulla sed consectetur amet.

Learn More

More Ways to Get Involved

Advocate for Glaucoma

  • Bullet goes here lorem ispum dolor sit amet donc elit.
  • Bullet goes here lorem ispum dolor sit amet donc elit.
  • Bullet goes here lorem ispum dolor sit amet donc elit.
  • Bullet goes here lorem ispum dolor sit amet donc elit.

Learn Through Our Blog Feed

Blog Title Goes Here Lorem Ipsum Dolor
Maecenas sed diam eget risus varius blandit sit amet non magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Read More

Blog Title Goes Here Lorem Ipsum Dolor
Maecenas sed diam eget risus varius blandit sit amet non magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Read More

Follow Us Instagram, Twitter & Facebook

Join us and other members of the glaucoma community to spread the word and celebrate World Glaucoma Week.

Show your support of World Glaucoma Week by following @livingwithglaucoma on Instagram, Twitter & Facebook. Share your story and help drive awareness of glaucoma by tagging your posts with (relevant hashtags).

Connect On:

Speak with an Expert

Looking for a glaucoma expert? Help is right around the corner. Use our Expert Locator today!

Find an Expert

Stay Connected

Sign up for our newsletter to receive the latest information about glaucoma, new treatments, research findings and more!

Glaukos will use the information you provide on this form to be in touch with you.

Consent(Required)
This field is for validation purposes and should be left unchanged.

INDICATION FOR USE
The iStent inject® W Trabecular Micro-Bypass System Model G2-W is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild-to-moderate primary open-angle glaucoma.

CONTRAINDICATIONS
The iStent inject® W is contraindicated in eyes with angle-closure glaucoma, traumatic, malignant, uveitic, or neovascular glaucoma, discernible congenital anomalies of the anterior chamber (AC) angle, retrobulbar tumor, thyroid eye disease, or Sturge-Weber Syndrome or any other type of condition that may cause elevated episcleral venous pressure.

WARNINGS
Gonioscopy should be performed prior to surgery to exclude congenital anomalies of the angle, PAS, rubeosis, or conditions that would prohibit adequate visualization of the angle that could lead to improper placement of the stent and pose a hazard.

MRI INFORMATION
The iStent inject® W is MR-Conditional, i.e., the device is safe for use in a specified MR environment under specified conditions; please see Directions for Use (DFU) label for details.

PRECAUTIONS
The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure (IOP). The safety and effectiveness of the iStent inject® W have not been established as an alternative to the primary treatment of glaucoma with medications, in children, in eyes with significant prior trauma, abnormal anterior segment, chronic inflammation, prior glaucoma surgery (except SLT performed > 90 days preoperative), glaucoma associated with vascular disorders, pseudoexfoliative, pigmentary or other secondary open-angle glaucomas, pseudophakic eyes, phakic eyes without concomitant cataract surgery or with complicated cataract surgery, eyes with medicated intraocular pressure (IOP) > 24 mmHg or unmedicated intraocular pressure (IOP) < 21 mmHg or > 36 mmHg, or for implantation of more or less than two stents.

ADVERSE EVENTS
Common postoperative adverse events reported in the iStent inject® randomized pivotal trial included stent obstruction (6.2%), intraocular inflammation (5.7% for iStent inject® vs. 4.2% for cataract surgery only), secondary surgical intervention (5.4% vs. 5.0%) and BCVA loss ≥ 2 lines ≥ 3 months (2.6% vs. 4.2%).

CAUTION
Federal law restricts this device to sale by, or on the order of, a physician. Please see DFU for a complete list of contraindications, warnings, precautions, and adverse events.

Text Optimizer